July 10, 2009

Amino Acid for Hair-Pulling Disorder

Ss_hairrestoration A new study suggests that supplementation with the amino acid N-acetylcysteine may help reduce symptoms of trichotillomania, an impulse-control disorder that causes people to pull out hair from various body parts.


Treatment for trichotillomania may include cognitive behavioral therapy, medications and/or support groups. However, the effectiveness of these therapies varies among individuals.

Earlier research has found that N-acetylcysteine may have beneficial effects on compulsive disorders by acting on the glutamate system.


In this latest trial, 50 adults with trichotillomania were randomly assigned to receive either 1,200-2,400 milligrams of N-acetylcysteine or placebo daily for 12 weeks.


According to the findings, published in the Archives of General Psychiatry, hair pull-symptoms were "much or very much improved" in 56 percent of patients in the N- acetylcysteine compared with 16 percent taking placebo. No side effects were reported during the study.


Although these results are promising, additional studies are needed to fully understand the potential relationship between N-acetylcysteine and trichotillomania.


For more information about impulse-control disorders, please visit Natural Standard’s Medical Conditions database.

July 01, 2009

Webinar Forum: Yoga - The Clinical Bottom Line

Ss_yoga

Natural Standard is offering a series of upcoming complimentary webinars on integrative medicine. Natural Standard remain impartial and offers these educational webinars as an informational public service. All webinars are recorded and archived at www.naturalstandard.com. 

This month, Natural Standard Associate Editor Regina Windsor, MPH, offers a presentation entitled, Yoga: The Clinical Bottom Line. Using the Natural Standard Grading Scale™ as a guide, Windsor discusses the available evidence concerning the therapeutic effectiveness of yoga in a variety of conditions.

Complimentary access is available until July 31, 2009. To listen to the webinar, please visit www1.gotomeeting.com/register/118961840. (Requires Windows Media Player).

Natural Standard values the opinions and views of its readers and welcomes feedback and questions about the latest webinar. Individuals are invited to leave comments below and/or e-mail questions@naturalstandard.com.

June 26, 2009

Breastfeeding Linked to Improved School Performance

Ss_breastfeeding A new study suggests that breastfeeding may be linked to improved academic performance compared to formula feeding.

Several earlier studies support this finding, but have not clearly proved that breastfeeding actually causes an increase in intelligence. For example, it is possible that mothers who breastfeed may be more educated or be more likely to engage in other behaviors that promote intelligence.  

In this latest study, researchers examined data from the National Longitudinal Study of Adolescent Health, which surveyed high school students and their parents. The study included 191 sibling pairs, in which one had been breastfed, while the other had been formula fed. Comparing siblings helped control other factors, such as family environment and parents’ intelligence, which may contribute to academic performance.

The authors found that between siblings, breastfed infants had a 12-14 percent higher grade point average (GPA) during high school and were slightly more likely to attend college than their formula-fed siblings. Both GPA and likelihood of attending college appeared to increase with each additional month of breastfeeding.

However, more research is needed to fully understand how breastfeeding affects cognitive function later in life.

Other evidence suggests that babies who are breastfed are less likely to develop infections (especially lung infections, ear infections, and diarrhea) during their first year of life than babies who are fed formulas. This is because the mother's breast milk contains important antibodies, enzymes, fats and proteins that help boost the baby's immune system. Although baby formulas contain all of the important vitamins and nutrients a growing baby needs, manufacturers have not been able to replicate all of the components in breast milk. Formulas lack antibodies and are more difficult for newborns to digest.

For more information about breastfeeding, please visit Natural Standard’s Medical Conditions database.

June 19, 2009

FDA Warning: Some Zicam Products may Impair Smell

Ss_commoncold The U.S. Food and Drug Administration (FDA) has warned Matrixx Initiatives to stop selling three over-the-counter Zicam® products, marketed as cold remedies, after more than 130 people reported developing long-lasting or permanent loss of smell (called anosmia). The warning applies to: Zicam Cold Remedy Nasal Gel®, Zicam Cold Remedy Nasal Swabs® and Zicam Cold Remedy Swabs, Kids Size (a discontinued product).

“Loss of sense of smell is a serious risk for people who use these products for relief from cold symptoms,” Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research (CDER), said in a statement released to the public. “We are concerned that consumers may unknowingly use a product that could cause serious harm, and therefore we are advising them not to use these products for any reason.”

Matrixx Initiatives will need to receive FDA approval in order to continue selling Zicam® products that are administered through the nose.

“Companies have an obligation to the public to demonstrate to the FDA that their products are safe, particularly when there is evidence they may be causing serious adverse events, and they are marketed for minor, self-limiting conditions like the common cold,” Deborah M. Autor, director of CDER’s Office of Compliance, said in a public statement.

Healthcare professionals and consumers are encouraged to report adverse events that may be related to the use of these products to the FDA's MedWatch Adverse Event Reporting program.

For more information about zinc, please visit Natural Standard’s Foods, Herbs & Supplements database.

June 12, 2009

Yellow Alder may Help Fight MRSA

Ss_mrsa New laboratory evidence suggests that yellow alder (Turnera ulmifolia) extract may enhance the effects of antibiotics in the treatment of methicillin-resistant Staphylococcus aureus (MRSA). MRSA is a type of bacteria that does not respond to treatment with certain antibiotics, including ampicillin (Principen®) and other penicillins.

Researchers tested the effects of an extract made from the Brazilian herb yellow alder, alone and in combination with antibiotics, against MRSA. They found that the herb alone did not have significant antimicrobial activity. However, when combined with other antibiotics (kanamycin and gentamicin), the anti-MRSA effects were significantly improved. 

“Extracts from Turnera ulmifolia could be used as a source of plant-derived natural products with resistance-modifying activity, constituting a new weapon against the problem of bacterial resistance to antibiotics demonstrated in MRSA strains,” The authors concluded in the journal BMC Complementary and Alternative Medicine.

Although these early results are promising, additional research in humans is needed to determine if this is a safe and effective therapy.

Traditionally, yellow alder has been used an anti-inflammatory and expectorant, although human evidence is limited.

Preliminary lab studies published earlier this year suggest that compounds in marijuana and honey may also have antibacterial effects against MRSA infections. However, more research is needed in humans before conclusions can be made.

MRSA is a serious medical condition that requires medical treatment. Integrative therapies should not replace or delay treatment with more proven techniques or therapies.

For more information about MRSA, please visit Natural Standard’s Medical Conditions database.

June 05, 2009

Webinar Forum: The Food Tree: The Food Pyramid revamped. A Rational Approach to Nutrition

Ss_nutritionaldeficiencies Natural Standard is offering a series of upcoming complimentary webinars on integrative medicine. Natural Standard remains impartial and offers these educational webinars as an informational public service. All webinars are recorded and archived at www.naturalstandard.com.


An innovator in nutrition, Dr. Ranveig Elvebakk specializes in treating diabetes and other metabolic illnesses with nutrition. Her book, The Food Tree, debunks diets and food pyramids, raising nutrition to a scientific level that individuals can understand and accomplish.

Complimentary access is available until June 30, 2009. To listen to the webinar, please visit www1.gotomeeting.com/register/439086584 (Requires Windows Media Player).


Natural Standard values the opinions and views of its readers and welcomes feedback and questions about the latest webinar. Individuals are invited to leave comments below and/or e-mail to questions@naturalstandard.com.

June 04, 2009

Comfrey may Improve Back Pain

Ss_comfrey An ointment made from comfrey root extract may significantly reduce acute upper and lower back pain, according to a new study published in the British Journal of Sports Medicine.

Comfrey (Symphytum officinale) is a perennial herb native to Europe and Asia. The herb has traditionally been applied to the skin for inflammation, pain and wound healing, and has been taken by mouth for digestive, breathing and gynecological conditions.

In the study, 120 adults with back pain were randomly assigned to receive either 4 grams of the comfrey-containing ointment Kytta-Salbe® or placebo three times daily for five days. The participants' pain was measured using a visual analogue scale.

By the end of the study, pain intensity improved by about 95 percent in the comfrey group compared to just 37 percent in the placebo group. The authors also noted that pain was relieved quickly, usually in less than one hour after the ointment was applied to the skin.

The authors concluded that "comfrey root extract showed a remarkably potent and clinically relevant effect in reducing acute back pain." These findings support several earlier human studies that suggest comfrey-containing creams may reduce inflammation and pain associated with sprains and muscle injuries.

Although comfrey has been traditionally used both orally and topically, recent evidence suggests that the herb may contain cancer-causing compounds and may lead to liver damage. As a result, various countries, including the United States, have asked companies to remove oral comfrey products from the market, and topical products are required to advise consumers not to use on broken skin. Other countries, such as Germany, allow topical comfrey products with a label including the maximal daily allowable levels of pyrrolidizine alkaloids of 100 micrograms and maximal use over six weeks per year.

For more information about integrative therapies for pain, please visit Natural Standard's  Comparative Effectiveness database.

Benefits of Natural Birthing Classes Unclear

Ss_pregnancy Learning relaxation and breathing techniques during pregnancy may not reduce the likelihood of needing an epidural or Caesarian section, researchers report in BJOG: An International Journal of Obstetrics and Gynaecology.


The Swedish study included 1,087 pregnant women and 1,064 of their partners. The participants were randomly assigned to attend four natural birthing classes or standard care classes. The natural birthing classes taught relaxation and breathing techniques, while the standard care classes emphasized pain relief and provided information about childbirth and parenting, modelled after the standard Swedish Antenatal Education Programme. The two-hour sessions began during the third trimester of pregnancy.


The number of women who requested pain-relieving medication during childbirth was similar in both groups, with just over half receiving epidurals. The number of vaginal and Caesarian deliveries was also similar between groups, although slightly more women in the natural childbirth group required the use of forceps or a ventouse. After the delivery, both groups reported similar rates of parental stress and satisfaction with the childbirth experience.


However, the authors note that additional research is needed to determine if results would be similar in other countries where prenatal preparation classes may be different.


Other integrative therapies have been suggested as beneficial before or during childbirth. For instance, some research suggests that water aerobics may help reduce pain during delivery. It has also been suggested that giving birth in water may reduce labor pain, duration of labor, perineal damage to the mother and birth complications.


For more information about natural childbirth techniques, please visit Natural Standard's Health & Wellness database.

Green Tea for Leukemia

Ss_greentea Mayo Clinic researchers have found that a compound in green tea called epigallocatechin gallate (EGCG) may have beneficial effects in patients with chonic lymphocytic leukemia (CLL).


CLL is one of four types of leukemia, which affects the blood and bone marrow. CLL typically progresses more slowly than other types of leukemia, and it is most common among adults who are 50 years of age or older.


In the Phase I clinical trial, 33 adults with CLL received eight different doses of Polyphenon E, a substance made from decaffeinated green tea that contains EGCG. Participants received 400-2,000 milligrams of Polyphenon E twice daily for one month.


According to the results, published in the Journal of Clinical Oncology, the supplement was well tolerated, and high doses helped decrease the white blood cells counts in one-third of patients with CLL, indicating cancer regression. Additionally, most people who had enlarged lymph nodes at the start of the study experienced at least a 50 percent reduction in lymph node size.


The research is now undergoing a second phase of clinical testing in which CLL patients will each receive 2,000 milligrams of Polyphenon E twice daily.


For more information about green tea, please visit Natural Standard's Foods, Herbs & Supplements database.

Aspirin Therapy Questioned

Ss_strokerisk A new research analysis published in the Lancet questions traditional recommendations for daily, low-dose aspirin therapy.


Doctors often recommend aspirin as a preventative measure against stroke and heart attack in people who are either at risk or have histories of these conditions. However, according to the meta-analysis, the potential risks of bleeding might outweigh the benefits if the person has not already had a heart attack or stroke.


The researchers analyzed data from six "primary prevention" studies that tested the effects of aspirin in 95,000 people with low-to-average risk factors for heart disease. They also analyzed 16 "secondary prevention" studies, which included 17,000 high-risk patients who already had a heart attack or stroke.

In both the low- and high-risk groups, the risk of non-fatal heart attack decreased by about 20 percent. However, in the lower-risk group, aspirin did not improve the risk of stroke or death from vascular problems. Additionally, aspirin therapy was linked to a statistically significant 33 percent increased risk of internal bleeding. This risk, according to the authors, outweighed the potential benefits.


In contrast, the analysis suggests that the benefits outweighed the risk of serious adverse effects in people who already had a heart attack or stroke. The authors concluded that only people with previous histories of heart attack or stroke should be advised to take a daily aspirin.


The American Heart Association (AHA) recommends that people talk to their doctors before beginning aspirin therapy because the risks and benefits vary for each person.


In a related study, researchers report that injections of nano-silver particles helped prevent blood clots in mice. The silver worked by preventing platelet surface proteins in the blood from clumping together. Unlike other anticoagulants, the nano-silver did not affect other proteins in the blood that help form clots, which may translate into a reduce risk of uncontrolled bleeding. However because this study was done in animals, it is unclear if this therapy would be safe and effective in humans. Additional clinical research is warranted.


For more information about stroke and heart attack, please visit Natural Standard's Medical Conditions database.